30493-41-5

Basic information

• Product Name: Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)-
• Synonyms: Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)-;1-(6-bromimidazo[1,2-a]pyridin-3-yl)Ethanone;1-(6-bromoimidazo[1,2-a]pyridin-3-yl)ethanone;1-(6-bromoimidazo[1,2-a]pyridin-3-yl)ethanone(WXC05184)
• CAS NO: 30493-41-5
• Molecular Formula: C₉H₇BrN₂O
• Molecular Weight: 239.06868
• Mol File: 30493-41-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)-(30493-41-5)
• EPA Substance Registry System: Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)-(30493-41-5)

Safety Data

• Hazardous Substances Data: 30493-41-5(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-(6-bromoimidazo [1,2-a] pyridin-3-yl)- is a chemical compound with the molecular formula C11H9BrN2O. It is a derivative of imidazo[1,2-a]pyridine, with a bromine atom attached to the sixth position of the imidazo ring. Ethanone, 1-(6-broMiMidazo[1,2-a]pyridin-3-yl)- is commonly used in research and pharmaceutical applications, particularly in the development of new drugs and medications. Its specific properties and potential uses in these fields would depend on its exact structure and reactivity, which would need to be determined through further analysis and experimentation.

Upstream product

• 474706-74-6 6-bromo-3-iodoimidazo[1,2-a]pyridine 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 1072-97-5 5-bromo-2-pyridylamine 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 598-31-2 1-bromoacetone 
• 138240-34-3 (E)-N’-(5-bromopyridin-2-yl)-N,N-dimethylformamidine 
• 78-95-5 chloroacetone 

Downstream Products

• 1276110-10-1 N-(5-(3-(1H-pyrazol-3-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 
• 1276110-02-1 N-(5-(3-acetylimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 

Relevant articles and documents

DERIVATIVES OF 4-(IMIDAZO[L,2-A]PYRIDIN-3-YL)-N-(PYRIDINYL)PYRIMIDIN- 2-AMINE AS THERAPEUTIC AGENTS

A novel class of heteroaryl compounds for use in the prevention and/or treatment of proliferative diseases and conditions including cancers. The compounds are considered to be capable of inhibiting cell proliferation by inhibiting the activity of FLT3 and its mutant forms and/or other protein kinases such as CDKs. The compounds have the general structure I:

2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS AND METHODS OF USE

The invention described herein comprises compounds of formula (IV) and a method of treating cancer comprising administering to a subject having cancer one of the compounds in conjunction with another therapeutic treatment of cancer. The compounds (IV) inhibit signaling by a member of the TGF-β superfamily such as Nodal or Activin.

THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS

Invented is a method of inhibiting the activity/function of PB kinases using thiozolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiozolidinedione derivatives.